![G. Kahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G. Kahn
Direktor/Vorstandsmitglied bei
SOLID BIOSCIENCES INC.
Vermögen: 21 726 $ am 31.05.2026
Profil
G.
Clare Kahn currently works at Solid Biosciences, Inc., as Independent Director from 2021, Stoke Therapeutics, Inc., as Independent Director from 2026, and Clare Kahn Pharma Consulting LLC, as President from 2016.
Dr. Kahn also formerly worked at Pfizer Inc., as Vice President-Global Innovative Pharma from 2014 to 2016, GSK Plc, as Vice President-Regulatory Affairs from 1999 to 2010, the University of Pennsylvania, as Assistant Professor from 1981 to 1985, and X-Vax Technology, Inc., as Chief Regulatory & Preclinical Development Officer from 2018 to 2019.
Dr. Kahn received her doctorate degree in 1981 from Royal Postgraduate Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 2.960 ( 0 % ) | 21 726 $ | 31.05.2026 |
Aktive Positionen von G. Kahn
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLID BIOSCIENCES INC. | Direktor/Vorstandsmitglied | 02.03.2021 |
| STOKE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.04.2026 |
Clare Kahn Pharma Consulting LLC | Präsident | 01.06.2016 |
Ehemalige bekannte Positionen von G. Kahn
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.06.2016 |
| GSK PLC | General Counsel | 01.01.2010 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1985 |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von G. Kahn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Royal Postgraduate Medical School
 Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clare Kahn Pharma Consulting LLC |
